James M. Eudicone - Concepedia

Author

James M. Eudicone

Also Known As

Eudicone, James, J EUDICONE, J Eudicone, J M Eudicone, J. Eudicone, J. M. Eudicone, J.M. Eudicone, JAMES EUDICONE, James M. Eudicone, James Eudicone

127

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (Germany)AstraZeneca (United States)Otsuka (United States)Bristol-Myers Squibb (United States)Johns Hopkins University

About

James M. Eudicone is an author at Bristol-Myers Squibb (Germany) specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	454
2	Social Sciences	5	5	118
3	Allergy	3	3	108
4	Public Health	2	2	96
5	Behavioral Sciences	1	1	16

James M. Eudicone

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Controlled Trial Investigating the Safety and Efficacy of Aripiprazole in the Long-Term Maintenance Treatment of Pediatric Patients With Irritability Associated With Autistic Disorder Robert L. Findling, Raymond Mankoski, Karen Timko, The Journal of Clinical Psychiatry	2014	103
Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder Trisha Suppes, James M. Eudicone, Robert D. McQuade, Journal of Affective Disorders PsychiatryPsychotropic MedicationDepressionMixed EpisodesPharmacotherapy	2007	84
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study Matthew Byerly, Ronald N. Marcus, Quynh-Van Tran, Schizophrenia Research PsychiatryMedicinePsychotropic MedicationProlactin LevelsPsychopharmacology	2008	83
Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure Kevin R. Murphy, Bradley E. Chipps, David A. Beuther, The Journal of Allergy and Clinical Immunology In Practice AsthmaAsthma ImpairmentRisk QuestionnaireAllergyMedicine	2020	71
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression David E. Kemp, Stephen J. Ganocy, Martin Brecher, Journal of Affective Disorders PsychiatryMood SymptomMedicineIi DepressionDepression	2010	61
Comparative Assessment of the Incidence and Severity of Tardive Dyskinesia in Patients Receiving Aripiprazole or Haloperidol for the Treatment of Schizophrenia Del D. Miller, James M. Eudicone The Journal of Clinical Psychiatry	2007	56
Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study David J. Muzina, C. Momah, James M. Eudicone, International Journal of Clinical Practice	2008	52
Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis David C. Steffens, J. Craig Nelson, James M. Eudicone, International Journal of Geriatric Psychiatry	2010	50
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: A post-hoc, pooled analysis of two large, placebo-controlled studies J. Craig Nelson, Raymond Mankoski, Ross A. Baker, Journal of Affective Disorders Core SymptomsPsychopathologyPsychiatryMood SymptomPsychotropic Medication	2009	43
Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder David E. Kemp, Joseph R. Calabrese, Quynh-Van Tran, The Journal of Clinical Psychiatry	2010	33

Page 1